Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Feb 6;15(4):1025. doi: 10.3390/cancers15041025

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Relative changes in the functional tumor volume (FTV) measurements and their mean (red circle) corresponding to optimal percentage enhancement (PE) and signal enhancement ratio (SER) for patients with pathologic complete response (pCR) and non-pCR. Plots correspond to (a,b) changes in FTV from baseline (BL) to after the second cycle of neoadjuvant systemic therapy (NAST) (C2), measured on images obtained 1 min (a) and 2.5 min (b) after contrast agent injection; and (c,d) changes in FTV from baseline to after the fourth cycle of NAST (C4), measured on images obtained 1 min (c) and 2.5 min (d) after contrast agent injection.